Sodium-glucose cotransporter 2 inhibitor canagliflozin alleviates vascular calcification through suppression of nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3 inflammasome

被引:24
|
作者
Chen, An [1 ,2 ]
Lan, Zirong [1 ,2 ]
Li, Li [3 ]
Xie, Luting [1 ,2 ]
Liu, Xiaoyu [1 ,2 ]
Yang, Xiulin [1 ,2 ]
Wang, Siyi [1 ,2 ]
Liang, Qingchun [4 ]
Dong, Qianqian [1 ,2 ]
Feng, Liyun [1 ,2 ]
Li, Yining [1 ,2 ]
Ye, Yuanzhi [1 ,2 ]
Fu, Mingwei [1 ,2 ]
Lu, Lihe [5 ]
Yan, Jianyun [1 ,2 ]
机构
[1] Southern Med Univ, Zhujiang Hosp, Heart Ctr, Dept Cardiol,Lab Heart Ctr, 253 Ind Ave, Guangzhou 510280, Peoples R China
[2] Guangdong Prov Biomed Engn Technol Res Ctr Cardio, Guangdong Prov Key Lab Cardiac Funct & Microcircu, 253 Ind Ave, Guangzhou 510280, Peoples R China
[3] Jinan Univ, Guangzhou Red Cross Hosp, Dept Cardiol, 396 Tongfu Middle Rd, Guangzhou 510220, Peoples R China
[4] Southern Med Univ, Affiliated Hosp 3, Dept Anesthesiol, 183 West Zhongshan Ave, Guangzhou 510630, Peoples R China
[5] Sun Yat Sen Univ, Zhongshan Med Sch, Dept Pathophysiolgy, 74 Zhongshan Er Rd, Guangzhou 510080, Peoples R China
基金
中国国家自然科学基金;
关键词
Canagliflozin; Vascular calcification; Vascular smooth muscle cell; Chronic kidney disease; NLRP3; SGLT2; INHIBITORS; KIDNEY; DAPAGLIFLOZIN; DYSFUNCTION; ACTIVATION;
D O I
10.1093/cvr/cvad119
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Vascular calcification (VC) is prevalent in pathological processes such as diabetes, chronic kidney disease (CKD), and atherosclerosis, but effective therapies are still lacking by far. Canagliflozin (CANA), a sodium-glucose cotransporter 2 inhibitor, has been approved for the treatment of type 2 diabetes mellitus and exhibits beneficial effects against cardiovascular disease. However, the effect of CANA on VC remains unknown. In this study, we hypothesize that CANA protects against VC. Methods and results Micro-computed tomography analysis and alizarin red staining revealed that CANA treatment prevented aortic calcification in CKD rats and in VitD3-overloaded mice. Moreover, CANA alleviated the calcification of rat and human arterial rings. Alizarin red staining revealed that calcification of rat and human vascular smooth muscle cells (VSMCs) was attenuated by CANA treatment and this phenomenon was confirmed by calcium content assay. In addition, CANA downregulated the expression of osteogenic differentiation markers Runx2 and BMP2. Of interest, qPCR and western blot analysis revealed that CANA downregulated the expression of the nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3 (NLRP3), and the downstream signalling molecules Caspase-1 and IL-1 beta in VSMCs as well. Both NLRP3 inhibitor MCC950 and knockdown of NLRP3 by siRNA independently resulted in decreased calcification of VSMCs. By contrast, activation of NLRP3 exacerbated VSMC calcification, and this effect was prevented by the addition of CANA. Conclusions Our study for the first time demonstrates that CANA exerts a protective effect on VC at least partially via suppressing the NLRP3 signalling pathway. Therefore, supplementation of CANA as well as inhibition of NLRP3 inflammasome presents a potential therapy for VC. [GRAPHICS] .
引用
收藏
页码:2368 / 2381
页数:14
相关论文
共 49 条
  • [1] Targeting NLRP3 (Nucleotide-Binding Domain, Leucine-Rich-Containing Family, Pyrin Domain-Containing-3) Inflammasome in Cardiovascular Disorders
    Wang, Zheng
    Hu, Wei
    Lu, Chenxi
    Ma, Zhiqiang
    Jiang, Shuai
    Gu, Chunhu
    Acuna-Castroviejo, Dario
    Yang, Yang
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38 (12) : 2765 - 2779
  • [2] Trimethylamine-N-Oxide Promotes Vascular Calcification Through Activation of NLRP3 (Nucleotide-Binding Domain, Leucine-Rich-Containing Family, Pyrin Domain-Containing-3) Inflammasome and NF-κB (Nuclear Factor κB) Signals
    Zhang, Xiuli
    Li, Yining
    Yang, Pingzhen
    Liu, Xiaoyu
    Lu, Lihe
    Chen, Yanting
    Zhong, Xinglong
    Li, Zehua
    Liu, Hailin
    Ou, Caiwen
    Yan, Jianyun
    Chen, Minsheng
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2020, 40 (03) : 751 - 765
  • [3] Regulation and Function of the Nucleotide Binding Domain Leucine-Rich Repeat-Containing Receptor, Pyrin Domain-Containing-3 Inflammasome in Lung Disease
    Lee, Seonmin
    Suh, Gee-Young
    Ryter, Stefan W.
    Choi, Augustine M. K.
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2016, 54 (02) : 151 - 160
  • [4] PINGCHUAN FORMULA IMPROVE AIRWAY REMODELING VIA REGULATION OF THE NUCLEOTIDE-BINDING DOMAIN, LEUCINE-RICH-CONTAINING FAMILY, PYRIN DOMAIN-CONTAINING-3/INTERLEUKIN-1(3 AND C-JUN N-TERMINAL KINASE PATHWAYS
    Xu, W. -c.
    Lu, Z. -y.
    Liu, X. -m.
    Wu, R. -f.
    Cao, L.
    Chen, L. -n.
    Chen, S. -y.
    Yu, J. -e.
    Zhuang, C.
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2024, 75 (05): : 499 - 510
  • [5] Inhibition of the nucleotide-binding domain, leucine-rich containing family, pyrin-domain containing 3 inflammasome reduces the severity of experimentally induced acute pancreatitis in obese mice
    York, Jason M.
    Castellanos, Karla J.
    Cabay, Robert J.
    Fantuzzi, Giamila
    TRANSLATIONAL RESEARCH, 2014, 164 (04) : 259 - 269
  • [6] PRODIGIOSIN IMPROVES ACUTE LUNG INJURY IN A RAT MODEL OF RHEUMATOID ARTHRITIS VIA DOWN-REGULATING THE NUCLEAR FACTOR-KAPPAB/NUCLEOTIDE-BINDING DOMAIN, LEUCINE-RICH-CONTAINING FAMILY, PYRIN DOMAIN-CONTAINING-3 SIGNALING PATHWAY
    Chen, P.
    Wu, H.
    Bian, T.
    Yang, L.
    Jiang, H.
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2023, 74 (01): : 43 - 54
  • [7] Scutellarin Alleviates Diabetic Retinopathy via the Suppression of Nucleotide-Binding Oligomerization Domain (NOD)-Like Receptor Pyrin Domain Containing Protein 3 Inflammasome Activation
    Yang, Lina
    Li, Zheming
    Fang, Jian
    CURRENT EYE RESEARCH, 2024, 49 (02) : 180 - 187
  • [8] Nucleotide-binding domain, leucine-rich repeat, and pyrin domain-containing protein 3 inflammasome: From action mechanism to therapeutic target in clinical trials
    Zhang, Chun-Ye
    Liu, Shuai
    Sui, Yu-Xiang
    Yang, Ming
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2025, 17 (02)
  • [9] NLR, the nucleotide-binding domain leucine-rich repeat containing gene family
    Ye, Zhengmao
    Ting, Jenny Pan-Yun
    CURRENT OPINION IN IMMUNOLOGY, 2008, 20 (01) : 3 - 9
  • [10] Involvement of Nucleotide-Binding Oligomerization Domain-Like Receptor Family Pyrin Domain Containing 3 Inflammasome in the Pathogenesis of Liver Diseases
    Shi, Congjian
    Yang, Hongqin
    Zhang, Zhenghong
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8